Professional Advisory Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227K | Hold |
1,450
| – | – | 0.03% | 87 |
|
|
2026
Q1 | $221K | Hold |
1,450
| – | – | 0.03% | 78 |
|
|
2025
Q4 | $200K | Buy |
+1,450
| New | +$190K | 0.03% | 79 |
|
|
2023
Q3 | – | Sell |
-2,630
| Closed | -$265K | – | 70 |
|
|
2023
Q2 | $265K | Hold |
2,630
| – | – | 0.04% | 63 |
|
|
2023
Q1 | $242K | Sell |
2,630
-150
| -5% | -$13.1K | 0.04% | 69 |
|
|
2022
Q4 | $252K | Buy |
+2,780
| New | +$234K | 0.04% | 66 |
|
|
2022
Q2 | – | Sell |
-2,627
| Closed | -$231K | – | 76 |
|
|
2022
Q1 | $231K | Sell |
2,627
-276,159
| -99% | -$23.9M | 0.03% | 73 |
|
|
2021
Q4 | $24.4M | Buy |
278,786
+11,007
| +4% | +$914K | 3.32% | 12 |
|
|
2021
Q3 | $21.9M | Buy |
267,779
+19,077
| +8% | +$1.72M | 3.22% | 16 |
|
|
2021
Q2 | $22.7M | Buy |
248,702
+2,846
| +1% | +$253K | 3.29% | 12 |
|
|
2021
Q1 | $21M | Buy |
245,856
+17,885
| +8% | +$1.6M | 3.22% | 16 |
|
|
2020
Q4 | $21.5M | Buy |
227,971
+3,884
| +2% | +$339K | 3.46% | 9 |
|
|
2020
Q3 | $19.5M | Buy |
224,087
+19,982
| +10% | +$1.73M | 3.48% | 11 |
|
|
2020
Q2 | $17.8M | Buy |
204,105
+3,520
| +2% | +$304K | 3.43% | 12 |
|
|
2020
Q1 | $16.5M | Sell |
200,585
-2,369
| -1% | -$211K | 3.84% | 10 |
|
|
2019
Q4 | $19.2M | Buy |
202,954
+4,780
| +2% | +$429K | 3.42% | 11 |
|
|
2019
Q3 | $17.2M | Sell |
198,174
-1,050
| -0.5% | -$94.3K | 3.27% | 14 |
|
|
2019
Q2 | $18.2M | Sell |
199,224
-41,074
| -17% | -$3.48M | 3.53% | 10 |
|
|
2019
Q1 | $20.7M | Sell |
240,298
-1,620
| -0.7% | -$130K | 4.16% | 2 |
|
|
2018
Q4 | $18.6M | Sell |
241,918
-20,777
| -8% | -$1.62M | 4.14% | 2 |
|
|
2018
Q3 | $20.3M | Sell |
262,695
-6,577
| -2% | -$486K | 4% | 2 |
|
|
2018
Q2 | $18.2M | Buy |
269,272
+25,042
| +10% | +$1.73M | 3.76% | 7 |
|
|
2018
Q1 | $17.7M | Sell |
244,230
-1,019
| -0.4% | -$77.6K | 3.83% | 6 |
|
|
2017
Q4 | $18.5M | Sell |
245,249
-1
| -0% | -$75 | 3.89% | 7 |
|
|
2017
Q3 | $18.9M | Sell |
245,250
-4,442
| -2% | -$335K | 4.02% | 3 |
|
|
2017
Q2 | $18.7M | Sell |
249,692
-12,955
| -5% | -$918K | 4.05% | 2 |
|
|
2017
Q1 | $17.5M | Sell |
262,647
-3,566
| -1% | -$238K | 3.87% | 5 |
|
|
2016
Q4 | $17.4M | Buy |
266,213
+33,175
| +14% | +$2.15M | 4.04% | 5 |
|
|
2016
Q3 | $16.5M | Sell |
233,038
-54
| -0% | -$3.94K | 3.76% | 7 |
|
|
2016
Q2 | $17.2M | Buy |
233,092
+2,339
| +1% | +$162K | 3.94% | 4 |
|
|
2016
Q1 | $15M | Buy |
230,753
+26,590
| +13% | +$1.81M | 3.54% | 10 |
|
|
2015
Q4 | $15.7M | Buy |
204,163
+67,562
| +49% | +$5.37M | 3.76% | 11 |
|
|
2015
Q3 | $11.3M | Sell |
136,601
-50,775
| -27% | -$4.52M | 2.82% | 17 |
|
|
2015
Q2 | $16.5M | Sell |
187,376
-1,198
| -0.6% | -$110K | 3.96% | 7 |
|
|
2015
Q1 | $16.7M | Buy |
188,574
+37,801
| +25% | +$3.35M | 4% | 6 |
|
|
2014
Q4 | $12.5M | Sell |
150,773
-232
| -0.2% | -$19.2K | 2.92% | 18 |
|
|
2014
Q3 | $12.7M | Sell |
151,005
-633
| -0.4% | -$51.2K | 3.08% | 14 |
|
|
2014
Q2 | $12.3M | Sell |
151,638
-62,801
| -29% | -$4.94M | 2.99% | 15 |
|
|
2014
Q1 | $16.3M | Sell |
214,439
-8,794
| -4% | -$641K | 4.08% | 5 |
|
|
2013
Q4 | $16.1M | Sell |
223,233
-1,483
| -0.7% | -$103K | 4.18% | 6 |
|
|
2013
Q3 | $15.4M | Buy |
224,716
+1,241
| +0.6% | +$82.1K | 4.36% | 3 |
|
|
2013
Q2 | $14.2M | Buy |
+223,475
| New | +$14.5M | 4.23% | 6 |
|
Other funds holding NVS
LMFP
SI
GGI
QCM
MIM
DLA
MGIA
ERP
CCM
Professional Advisory Services's NVS Position: Q2 2026 in Review
Professional Advisory Services held its Novartis (NVS) position steady in Q2 2026 at 1,450 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #87.
Professional Advisory Services first reported a position in NVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $24.4M in Q4 2021. 325 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Professional Advisory Services held 1,450 shares of Novartis worth $227K as of Q2 2026.
- Professional Advisory Services left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.03% of Professional Advisory Services's portfolio in Q2 2026, its #87 holding.
- Professional Advisory Services first reported a position in Novartis in Q2 2013 and has held it in 42 quarters since.
- Professional Advisory Services's Novartis position peaked at $24.4M in Q4 2021.
- 325 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.